U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period
U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period, according to a survey by employee benefits provider, Unum. Employees also plan to pay more attention to the benefits their employers offer.
The survey, compiled of 1,500 full-time U.S. workers in August 2021, shared more than half of workers said they are more likely to stay with their employer because of the benefits their employer provides. However, the same amount of employees (57%) plan to enroll in benefits they were not enrolled in this year because they (68%) are more concerned about planning their family's financial needs, (66%) interested in company benefits, and (42%) concerned about their mental health.
"Choosing your benefits is one of the most important financial decisions you'll make this year," said Rob Hecker, vice president of Global Total Rewards at Unum. "The ongoing pandemic reminds us of the need to be prepared. You can protect you and your family's financial future with the right benefits."
Data from the survey found new trends due to the ongoing pandemic:
Eight in 10 employers believe the pandemic has made employees more interested in or aware of the benefits the organization offers.
An article by NPR recommends to learn what's predictable about your health and to educate yourself further on what plans can offer you. Most importantly, it's crucial to be aware of your deadline.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More